Pay in 4 interest-free payments of $6.59 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
Around half say they dont know whether taking GLP-1 drugs for obesity or diabetes is safe and more than half say they need more information about GLP-1 drugs
Wang L, Wang N, Zhang W, Cheng X, Yan Z, Shao G, et al
Medical providers need a broad spectrum of solutions to address the needs of customers and that includes those with weight challenges
These drugs are part of an emerging class of nutrient-stimulated hormone-based therapeutics, acting as incretin mimetics to target G-proteincoupled receptors like GLP-1, glucose-dependent insulinotropic polypeptide (GIP), and glucagon
US$ 29.23
US$ 29.20
US$ 25.95
US$ 23.41
US$ 26.38
